TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biobasiq Sverige AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
19,931
|
17,734
|
12,064 |
| Financial expenses |
34
|
30
|
39 |
| Earnings before taxes |
1,311
|
49
|
708 |
| EBITDA |
1,283
|
44
|
747 |
| Total assets |
6,253
|
5,307
|
4,917 |
| Current assets |
6,253
|
5,307
|
4,917 |
| Current liabilities |
1,736
|
1,712
|
1,377 |
| Equity capital |
4,517
|
3,595
|
3,540 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
72.2%
|
67.7%
|
72.0% |
| Turnover per employee |
9,966
|
8,867
|
6,032 |
| Profit as a percentage of turnover |
6.6%
|
0.3%
|
5.9% |
| Return on assets (ROA) |
21.5%
|
1.5%
|
15.2% |
| Current ratio |
360.2%
|
310.0%
|
357.1% |
| Return on equity (ROE) |
29.0%
|
1.4%
|
20.0% |
| Change turnover |
2,784
|
5,607
|
1,314 |
| Change turnover % |
16%
|
46%
|
12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.